openPR Logo
Press release

PEGylated Proteins Global Market Report 2024 - By Share, Size, Demand And Trends, Forecast To 2033

07-17-2024 07:11 AM CET | Health & Medicine

Press release from: The Business research company

PEGylated Proteins Market

PEGylated Proteins Market

"The new report published by The Business Research Company, titled ""PEGylated Proteins Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the PEGylated proteins market size has grown rapidly in recent years. It will grow from $1.29 billion in 2023 to $1.47 billion in 2024 at a compound annual growth rate (CAGR) of 13.7%. The PEGylated proteins market size is expected to see rapid growth in the next few years. It will grow to $2.47 billion in 2028 at a compound annual growth rate (CAGR) of 13.8%.

Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16145&type=smp

Rising Prevalence Of Lifestyle Diseases Is Driving Growth Of The PEGylated Proteins Market 
The increasing prevalence rate of lifestyle diseases is expected to propel the growth of the PEGylated proteins market going forward. Lifestyle diseases refer to health conditions primarily caused by unhealthy habits and lifestyle choices such as poor diet, lack of physical activity, and smoking. Lifestyle diseases are on the rise due to a combination of factors such as less physical activity, unhealthier diets high in processed foods, and increased stress. PEGylated proteins are utilized in treating lifestyle diseases by enhancing the efficacy, duration, and targeted delivery of therapeutic agents for conditions including cardiovascular diseases, diabetes, and certain cancers. For instance, in October 2022, according to the World Heart Federation (WHF), a Switzerland-based non-governmental organization, the number of cardiovascular disease deaths is projected to rise from an estimated 18.9 million in 2020 to over 22.2 million in 2030. Additionally, in December 2021, according to the IDF Diabetes Atlas 10th Edition report published by the International Diabetes Federation, a Belgium-based diabetes community, 537 million adults aged 20 to 79 years worldwide were currently diagnosed with diabetes, representing 1 in 10 individuals. Therefore, the increasing prevalence rate of lifestyle diseases is driving the growth of the PEGylated proteins market.

Developments In Drug Delivery Mechanisms For Driving Biomedical Innovation
Major companies operating in the PEGylated protein market are developing innovative products, such as PEGylation reagents, to gain a competitive edge in the market. PEGylation reagents refer to chemical compounds that attach polyethylene glycol (PEG) chains to biomolecules, altering their properties for various biomedical applications. For instance, in May 2023, Creative Enzymes, a US-based supplier of food additives and enzymes, launched DSPE-PEG-Maleimide for targeted drug delivery. DSPE-PEG-Maleimide (DSPE-PEG-MAL) is a linear heterobifunctional PEGylation reagent containing DSPE phospholipids and maleimide. It is a useful self-assembly reagent that can be used to prepare PEGylated liposomes or micelles, and it also provides thiol or cysteine reactive maleimide groups. It is often used in targeted drug delivery.

The PEGylated proteins market covered in this report is segmented -
1) By Product: Consumable And Services, PEGylation Kits And Reagents, Monofunctional Linear PEGs, Bifunctional PEGs, Services, Other Products
2) By Protein Type: Colony Stimulating Factors, Interferons, Erythropoietin, Recombinant Factor VII, Other Protein Types
3) By Application: Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, Other Applications
4) By End User: Pharmaceuticals, Biotechnology Companies, Contract Research Organizations, Academic Research Institutes

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16145&type=discount

Major companies operating in the PEGylated proteins market are Merck & Co. Inc., Bayer AG, Bristol Myers Squibb Company, AstraZeneca PLC, Roche Holding AG, Gilead Sciences Inc., Novo Nordisk A/S, Evonik Industries AG, Viatris Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Lonza Group Ltd., Jazz Pharmaceuticals plc, Ipsen Pharma, Kyowa Kirin Co. Ltd., WuXi Biologics, BioMarin Pharmaceutical Inc., Ligand Pharmaceuticals Incorporated, Zydus Cadila, Enzon Pharmaceuticals Inc.

Contents of the report:
1. Executive Summary
2. PEGylated Proteins Market Report Structure
3. PEGylated Proteins Market Trends And Strategies
4. PEGylated Proteins Market - Macro Economic Scenario
5. PEGylated Proteins Market Size And Growth
…..
27. PEGylated Proteins Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/pegylated-proteins-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PEGylated Proteins Global Market Report 2024 - By Share, Size, Demand And Trends, Forecast To 2033 here

News-ID: 3584665 • Views:

More Releases from The Business research company

Comprehensive Insights Into The Global Electric Bikes And Scooters Market: Key Growth Drivers, Emerging Trends, Opportunities & Forecast 2025-2034
Comprehensive Insights Into The Global Electric Bikes And Scooters Market: Key G …
The electric bikes and scooters report outlines and analyzes the electric bikes and scooters (excluding e-mopeds or 2-wheelers) market, covering the historic period 2019-2024 and the forecast period 2024-2029 and 2034F. The study examines the market across all regions and major regional economies. The global electric bikes and scooters (excluding e-mopeds or 2 wheelers) market was valued at approximately $43.09310 billion in 2024, reflecting a CAGR of 12.12% since 2019. The
Geothermal Heat Pump Market Report 2025: Size, Trends, and Key Growth Insights for Global Expansion
Geothermal Heat Pump Market Report 2025: Size, Trends, and Key Growth Insights f …
The geothermal heat pump report outlines and analyzes the geothermal heat pump market, covering 2019-2024 as the historic period and 2024-2029, 2034F as the forecast period. The report examines the market across every region and assesses major economies within each region. The global geothermal heat pump market reached $4.40620 billion in 2024, increasing at a CAGR of 5.70% since 2019. The market is projected to grow from $4.40620 billion in 2024
Major Growth Driver Identified in 2025 VFX In Advertising Market: The Rise Of Social Media And Digital Platforms Fueling The Growth Of The Market Due To Increasing Demand For Engaging Visual Content
Major Growth Driver Identified in 2025 VFX In Advertising Market: The Rise Of So …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. VFX In Advertising Market Size Valuation Forecast: What Will the Market Be Worth by 2025? Over the past several years, the market size of vfx in advertising has seen robust growth. It is expected to expand from $2.8 billion in 2024 to a staggering $3.03 billion in 2025, exhibiting
Driving Web Content, Search Portals And Social Media Market Growth in 2025: The Role of Mobile Revolution How Increased Device Penetration And Data Consumption Fuel The Web Content, Search Portals, Seo Services, And Social Media Market
Driving Web Content, Search Portals And Social Media Market Growth in 2025: The …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Web Content, Search Portals And Social Media Market Size Growth Forecast: What to Expect by 2025? The market size for web content, search portals, and social media has seen quick expansion in the past few years. It's projected to expand from $682.14 billion in 2024 to $768.29 billion in

All 5 Releases


More Releases for PEG

Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy
Watertown, MA - October 24, 2024 - Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in drug development is more critical than ever. PEGylation provides numerous advantages, such as improved solubility, enhanced stability, and increased circulation time in the bloodstream. By
Biopharma PEG Expands Multi-Arm PEG Product Line
Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG linker product line, catering to the evolving needs of the medical and bioorganic fields. These advanced PEG linkers are available in various functional groups and molecular weights ranging from 1k to 40k, offering unmatched versatility and performance for research and development in cutting-edge medical applications. "Biopharma PEG is committed to delivering high-purity multi-arm
Biopharma PEG Supplies PEG Products Used For Infectious Disease Vaccines
As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. Advances in molecular technology have facilitated the development of other platforms, such as recombinant protein vaccines, nucleic acid vaccines, and viral vector vaccines, which have further diversified global vaccine development. Recombinant protein vaccines accounted for the largest proportion of all pipeline in development, 22% (215), due
Biopharma PEG Supplies PEG Products For Click Chemistry Reactions
What is "click chemistry"? "Click Chemistry", this is a literary name given to this kind of reaction by the Nobel Prize winner K.Burry Sharless, when the cards are put together, "click" (click). Simply put, it is to add two structures to two molecules respectively, and these two structures can be specifically combined to synthesize the required chemical molecules. One of the most famous click-chemistry reactions is the Cu-catalyzed azide-alkyne cycloaddition
Biopharma PEG Develops PEG Linkers for Antibody Drug Conjugates
Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy, which consists of monoclonal antibody (Antibody), linker (Linker) and active drug (Payload). So far, there are only 15 drugs on the market in the world. However, with the development of some perfect antibody modification techniques, advanced site-specific coupling techniques and powerful small-molecule toxins, ADC drug research has mushroomed and a large number of ADC drugs are in
Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked Into Hydrogels
Polyethylene (ethylene glycol) is a hydrophilic polymer that can have a very high water content when cross-linked into a network. Polyethylene glycol (PEG) is a suitable material for biological applications because it does not normally elicit an immune response. Since the 1970s, PEG has been used to modify therapeutic proteins and peptides in order to increase their solubility, reduce their toxicity, and prolong their cyclic half-lives. In the late 1970s,